New Delhi: The fourth corona vaccine is eagerly awaited in India.
This vaccine is from the American pharma company Moderna, which has got approval from the pharmaceutical company Cipla to import. According to Cipla, some official formalities are yet to be completed, as soon as they are completed, its supply will start in the government hospitals of the country. The effective efficacy of Moderna Vaccine has been reported to be up to 94 percent.
Last week, Cipla had sought approval from the government for the import of Moderna Covid-19 vaccine into India, which was approved by the government after getting the stamp of DGCI. Considering the efficacy of Moderna, it has proved to be the first choice of people in many countries.
